What is the share price of Nephro Care India Ltd (NEPHROCARE) today?
The share price of NEPHROCARE as on 11th July 2025 is ₹111.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nephro Care India Ltd (NEPHROCARE) share?
The past returns of Nephro Care India Ltd (NEPHROCARE) share are- Past 1 week: -1.02%
- Past 1 month: -11.00%
- Past 3 months: -18.54%
- Past 6 months: -33.01%
- Past 1 year: -48.83%
- Past 3 years: N/A%
- Past 5 years: -37.84%
What are the peers or stocks similar to Nephro Care India Ltd (NEPHROCARE)?
The peers or stocks similar to Nephro Care India Ltd (NEPHROCARE) include:What is the market cap of Nephro Care India Ltd (NEPHROCARE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nephro Care India Ltd (NEPHROCARE) is ₹183.99 Cr as of 11th July 2025.What is the 52 week high and low of Nephro Care India Ltd (NEPHROCARE) share?
The 52-week high of Nephro Care India Ltd (NEPHROCARE) is ₹378.80 and the 52-week low is ₹99.95.What is the PE and PB ratio of Nephro Care India Ltd (NEPHROCARE) stock?
The P/E (price-to-earnings) ratio of Nephro Care India Ltd (NEPHROCARE) is 50.55. The P/B (price-to-book) ratio is 12.25.Which sector does Nephro Care India Ltd (NEPHROCARE) belong to?
Nephro Care India Ltd (NEPHROCARE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Nephro Care India Ltd (NEPHROCARE) shares?
You can directly buy Nephro Care India Ltd (NEPHROCARE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nephro Care India Ltd
NEPHROCARE Share Price
111.604.57% (-5.35)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NEPHROCARE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NEPHROCARE Performance & Key Metrics
NEPHROCARE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 12.25 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.72 | 6.42 | 0.79% |
NEPHROCARE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NEPHROCARE Company Profile
Nephro Care India is an India-based healthcare provider that specializes in the treatment of kidney-related diseases.
MAXHEALTH
PE Ratio
110.16
110.16
1Y Return
35.87%
35.87%
Buy Reco %
75.00
75.00
APOLLOHOSP
PE Ratio
71.49
71.49
1Y Return
12.53%
12.53%
Buy Reco %
89.66
89.66
FORTIS
PE Ratio
74.55
74.55
1Y Return
62.57%
62.57%
Buy Reco %
92.86
92.86
PE Ratio
51.59
51.59
1Y Return
62.55%
62.55%
Buy Reco %
70.00
70.00
MEDANTA
PE Ratio
72.76
72.76
1Y Return
4.53%
4.53%
Buy Reco %
71.43
71.43
NEPHROCARE Forecast
NEPHROCARE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NEPHROCARE
NEPHROCARE
Income
Balance Sheet
Cash Flow
Annual Normal View
NEPHROCARE Income Statement
NEPHROCARE Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.55 | 1.83 | 3.42 | 18.21 | 27.96 | 47.56 | — | |||||||
Raw Materials | 0.00 | 1.25 | 1.63 | 5.28 | 8.95 | 40.16 | — | |||||||
| Power & Fuel Cost | 0.06 | 0.06 | 0.03 | 0.15 | 0.26 | |||||||||
| Employee Cost | 0.15 | 0.15 | 0.31 | 1.11 | 2.16 | |||||||||
| Selling & Administrative Expenses | 0.01 | 0.18 | 1.17 | 8.03 | 9.05 | |||||||||
| Operating & Other expenses | 0.31 | 0.03 | 0.16 | 0.22 | 0.79 | |||||||||
EBITDA | 0.02 | 0.16 | 0.12 | 3.42 | 6.75 | 7.40 | — | |||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.11 | 0.78 | 0.53 | 2.46 | — | |||||||
| PBIT | 0.02 | 0.15 | 0.01 | 2.64 | 6.22 | 4.94 | — | |||||||
| Interest & Other Items | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | 0.11 | — | |||||||
| PBT | -0.02 | 0.12 | -0.01 | 2.57 | 6.13 | 4.83 | — | |||||||
| Taxes & Other Items | 0.00 | 0.03 | 0.01 | 0.20 | 1.72 | 1.19 | — | |||||||
| Net Income | -0.02 | 0.09 | -0.02 | 2.37 | 4.41 | 3.64 | — | |||||||
| EPS | -1.00 | 4.50 | -0.04 | 2.37 | 4.03 | 2.38 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
NEPHROCARE Company Updates
NEPHROCARE Stock Peers
NEPHROCARE Past Performance & Peer Comparison
NEPHROCARE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation-basic on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nephro Care India Ltd | 50.55 | 12.25 | — |
| Max Healthcare Institute Ltd | 110.16 | 12.63 | 0.12% |
| Apollo Hospitals Enterprise Ltd | 71.49 | 14.12 | 0.39% |
| Fortis Healthcare Ltd | 74.55 | 6.75 | 0.13% |
NEPHROCARE Stock Price Comparison
Compare NEPHROCARE with any stock or ETFCompare NEPHROCARE with any stock or ETF
NEPHROCARE
NEPHROCARE Holdings
NEPHROCARE Shareholdings
NEPHROCARE Promoter Holdings Trend
NEPHROCARE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NEPHROCARE Institutional Holdings Trend
NEPHROCARE Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.54%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NEPHROCARE Shareholding Pattern
NEPHROCARE Shareholding Pattern
NEPHROCARE Shareholding History
NEPHROCARE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing NEPHROCARE stock
smallcases containing NEPHROCARE stock
Looks like this stock is not in any smallcase yet.
NEPHROCARE Events
NEPHROCARE Events
NEPHROCARE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NEPHROCARE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NEPHROCARE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NEPHROCARE has not given any dividends in last 5 years
NEPHROCARE Dividends
NEPHROCARE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNEPHROCARE Stock News & Opinions
NEPHROCARE Stock News & Opinions
Articles & Videos
Corporate
Nephro Care India to hold AGM
Nephro Care India announced that the 11th Annual General Meeting(AGM) of the company will be held on 28 August 2025.Powered by Capital Market - Live
2 days agoCapital Market - Live
Corporate
Nephro Care India schedules board meeting
Nephro Care India will hold a meeting of the Board of Directors of the Company on 10 July 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Nephro Care India to hold board meeting
Nephro Care India will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Nephro Care India to convene board meeting
Nephro Care India will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Nephro Care India to discuss results
Nephro Care India will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Nephro Care India to hold AGM
Nephro Care India announced that the 10th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Nephro Care India to announce Quarterly Result
Nephro Care India will hold a meeting of the Board of Directors of the Company on 20 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 143.99%, vs industry avg of 12.84%
Over the last 5 years, market share increased from 0% to 0.06%